Scottish Aquaculture Innovation Centre

JIOS Aerogel® Secures New Investment from MegaChem to Fund its Aerogel and Thermal Blade® Plants

Retrieved on: 
Monday, September 18, 2023

The funding will support JIOS Aerogel's two plants in Southeast Asia: its aerogel production facility and its new Singapore site for fully automated production of its Thermal Blade®.

Key Points: 
  • The funding will support JIOS Aerogel's two plants in Southeast Asia: its aerogel production facility and its new Singapore site for fully automated production of its Thermal Blade®.
  • Stephen Kang, Co-Founder and Managing Director of JIOS Aerogel, enthusiastically expressed, "We are thrilled to welcome MGT and MegaChem as investors, further bolstering the burgeoning aerogel market within the electric vehicle battery industry.
  • JIOS Aerogel's cutting-edge breakthrough, the Thermal Blade®, leverages the exceptional properties of aerogels to deliver superior thermal protection for battery cells, significantly enhancing their safety and performance.
  • Mr Sidney Chew, Managing Director of MegaChem, also expressed his enthusiasm, saying, "JIOS Aerogel has demonstrated the effectiveness of their distinctive and cost-efficient approach to aerogel manufacturing.

JIOS Aerogel® Secures New Investment from MegaChem to Fund its Aerogel and Thermal Blade® Plants

Retrieved on: 
Monday, September 18, 2023

The funding will support JIOS Aerogel's two plants in Southeast Asia: its aerogel production facility and its new Singapore site for fully automated production of its Thermal Blade®.

Key Points: 
  • The funding will support JIOS Aerogel's two plants in Southeast Asia: its aerogel production facility and its new Singapore site for fully automated production of its Thermal Blade®.
  • Stephen Kang, Co-Founder and Managing Director of JIOS Aerogel, enthusiastically expressed, "We are thrilled to welcome MGT and MegaChem as investors, further bolstering the burgeoning aerogel market within the electric vehicle battery industry.
  • JIOS Aerogel's cutting-edge breakthrough, the Thermal Blade®, leverages the exceptional properties of aerogels to deliver superior thermal protection for battery cells, significantly enhancing their safety and performance.
  • Mr Sidney Chew, Managing Director of MegaChem, also expressed his enthusiasm, saying, "JIOS Aerogel has demonstrated the effectiveness of their distinctive and cost-efficient approach to aerogel manufacturing.

DiagnaMed Provides Update for its Brain Health AI Platform, CERVAI™

Retrieved on: 
Wednesday, September 13, 2023

TORONTO, Sept. 13, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a generative artificial intelligence healthcare company, provides a development and commercialization update for CERVAI™, a brain health AI platform.

Key Points: 
  • TORONTO, Sept. 13, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a generative artificial intelligence healthcare company, provides a development and commercialization update for CERVAI™, a brain health AI platform.
  • A world first, CERVAI™ consists of a Brain Age Estimation and Brain Health Assessment tool.
  • The Brain Health Assessment tool generates clinician-observed measures and a brain health score.
  • Fabio Chianelli, Chairman and CEO of DiagnaMed, commented: “We are in the final stage of development for CERVAI™, our novel brain health AI platform.

The Department of Health - Abu Dhabi, Mass General Brigham, and International Center for Genetic Disease sign Declaration of Collaboration to Advance Life Sciences Research

Retrieved on: 
Thursday, June 15, 2023

ABU DHABI, UAE, June 15, 2023 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Declaration of Collaboration with Mass General Brigham's International Center for Genetic Disease (iCGD).

Key Points: 
  • ABU DHABI, UAE, June 15, 2023 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Declaration of Collaboration with Mass General Brigham's International Center for Genetic Disease (iCGD).
  • The agreement signed is intended to advance life sciences across three strategic pillars including clinical and translational research, capacity building and technology transfer and commercialisation.
  • The collaboration aims to enhance access to innovative solutions and treatments for patients in the United Arab Emirates (UAE) and beyond.
  • Through our research collaboration with the Abu Dhabi Department of Health we intend to leverage our collective knowledge, experience, and expertise to further advance biomedical science and enhance public health.

The Department of Health - Abu Dhabi, Mass General Brigham, and International Center for Genetic Disease sign Declaration of Collaboration to Advance Life Sciences Research

Retrieved on: 
Thursday, June 15, 2023

ABU DHABI, UAE, June 15, 2023 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Declaration of Collaboration with Mass General Brigham's International Center for Genetic Disease (iCGD).

Key Points: 
  • ABU DHABI, UAE, June 15, 2023 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Declaration of Collaboration with Mass General Brigham's International Center for Genetic Disease (iCGD).
  • The agreement signed is intended to advance life sciences across three strategic pillars including clinical and translational research, capacity building and technology transfer and commercialisation.
  • The collaboration aims to enhance access to innovative solutions and treatments for patients in the United Arab Emirates (UAE) and beyond.
  • Through our research collaboration with the Abu Dhabi Department of Health we intend to leverage our collective knowledge, experience, and expertise to further advance biomedical science and enhance public health.

The Department of Health - Abu Dhabi, Mass General Brigham, and International Center for Genetic Disease sign Declaration of Collaboration to Advance Life Sciences Research

Retrieved on: 
Wednesday, June 14, 2023

ABU DHABI, UAE, June 14, 2023 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Declaration of Collaboration with Mass General Brigham's International Center for Genetic Disease (iCGD).

Key Points: 
  • ABU DHABI, UAE, June 14, 2023 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Declaration of Collaboration with Mass General Brigham's International Center for Genetic Disease (iCGD).
  • The agreement signed is intended to advance life sciences across three strategic pillars including clinical and translational research, capacity building and technology transfer and commercialisation.
  • The collaboration aims to enhance access to innovative solutions and treatments for patients in the United Arab Emirates (UAE) and beyond.
  • Through our research collaboration with the Abu Dhabi Department of Health we intend to leverage our collective knowledge, experience, and expertise to further advance biomedical science and enhance public health.

The Department of Health - Abu Dhabi, Mass General Brigham, and International Center for Genetic Disease sign Declaration of Collaboration to Advance Life Sciences Research

Retrieved on: 
Wednesday, June 14, 2023

ABU DHABI, UAE, June 14, 2023 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Declaration of Collaboration with Mass General Brigham's International Center for Genetic Disease (iCGD).

Key Points: 
  • ABU DHABI, UAE, June 14, 2023 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Declaration of Collaboration with Mass General Brigham's International Center for Genetic Disease (iCGD).
  • The agreement signed is intended to advance life sciences across three strategic pillars including clinical and translational research, capacity building and technology transfer and commercialisation.
  • The collaboration aims to enhance access to innovative solutions and treatments for patients in the United Arab Emirates (UAE) and beyond.
  • Through our research collaboration with the Abu Dhabi Department of Health we intend to leverage our collective knowledge, experience, and expertise to further advance biomedical science and enhance public health.

BRP OFFICIALLY OPENS ITS FIRST EUROPEAN DESIGN AND INNOVATION CENTRE IN SOPHIA ANTIPOLIS

Retrieved on: 
Tuesday, April 11, 2023

SOPHIA ANTIPOLIS, France, April 11, 2023 /PRNewswire/ - BRP Inc. (TSX : DOO) (NASDAQ : DOOO) today inaugurates its first European Design and Innovation Centre.

Key Points: 
  • SOPHIA ANTIPOLIS, France, April 11, 2023 /PRNewswire/ - BRP Inc. (TSX : DOO) (NASDAQ : DOOO) today inaugurates its first European Design and Innovation Centre.
  • Located in Sophia Antipolis in the south of France, this new Centre reasserts the central role that BRP assigns to design and innovation as a growth driver.
  • The Centre, which will carry out advanced concept studies on sustainable urban mobility, will play a leading role in BRP's global electrification strategy.
  • "We are proud to inaugurate the Design and Innovation Centre in Sophia Antipolis, our first in Europe, which will allow us to strengthen our understanding of the market dynamics.

BRP OFFICIALLY OPENS ITS FIRST EUROPEAN DESIGN AND INNOVATION CENTRE IN SOPHIA ANTIPOLIS

Retrieved on: 
Tuesday, April 11, 2023

SOPHIA ANTIPOLIS, France, April 11, 2023 /PRNewswire/ -- BRP Inc. (TSX : DOO) (NASDAQ : DOOO) today inaugurates its first European Design and Innovation Centre.

Key Points: 
  • SOPHIA ANTIPOLIS, France, April 11, 2023 /PRNewswire/ -- BRP Inc. (TSX : DOO) (NASDAQ : DOOO) today inaugurates its first European Design and Innovation Centre.
  • Located in Sophia Antipolis in the south of France, this new Centre reasserts the central role that BRP assigns to design and innovation as a growth driver.
  • The Centre, which will carry out advanced concept studies on sustainable urban mobility, will play a leading role in BRP's global electrification strategy.
  • "We are proud to inaugurate the Design and Innovation Centre in Sophia Antipolis, our first in Europe, which will allow us to strengthen our understanding of the market dynamics.

17th Edition of Digital Transformation Summit: Qatar

Retrieved on: 
Wednesday, March 1, 2023

The 17th Edition of Digital Transformation Summit Qatar is taking place on 16th of March 2023 at The Westin Doha Hotel & Spa.

Key Points: 
  • The 17th Edition of Digital Transformation Summit Qatar is taking place on 16th of March 2023 at The Westin Doha Hotel & Spa.
  • At the summit, you will hear from top IT experts on emerging technologies, strategies, action plans and best practices towards building an agile digital organization.
  • "Organizational digital transformation is a key driver of economic growth and diversification that is in line with Qatar's 2030 National Vision.
  • Now in its 17th Edition, the Digital Transformation Series is coming to Qatar and is the ideal summit that will enable the public and private sectors to embrace technologies that will foster change and unlock operational efficiencies," said Rishikesh Shetty, CEO, of Exito Media Concepts, the organizer of the event.